Details of the Drug Reposition

General Information of This Drug (ID: DM9REBL)

Drug Name
DDP-225   DM9REBL
Synonyms AA-10021; AA-10025; AA-10026; 4-(2-fluorophenyl)-6-methyl-2-piperazin-1-ylthieno[2,3-d]pyrimidine hydrate hydrochloride
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Irritable bowel syndrome DIS27206 DD91.0 Phase 2 [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Chronic functional vomiting DISMKDJ2 DD90.4 Discontinued in Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Emerging drugs for irritable bowel syndrome. Expert Opin Emerg Drugs. 2006 May;11(2):293-313.